1972
DOI: 10.1017/s0033291700045645
|View full text |Cite
|
Sign up to set email alerts
|

Part 2. Improvement criteria in drug trials with neurotic patients

Abstract: SYNOPSISBased on the available research evidence, several rating and self-rating methods are recommended which appear to be suitable for the measurement of changes in distress in drug trials with neurotic patients.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
56
0

Year Published

1975
1975
2021
2021

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 92 publications
(57 citation statements)
references
References 115 publications
1
56
0
Order By: Relevance
“…The intermediate scores reflect worsening (8-6) or improvement (4-2) of symptoms. This scale was found to be a sensi tive and reliable method of detecting changes in response to treat ment [19].…”
Section: Methodsmentioning
confidence: 97%
“…The intermediate scores reflect worsening (8-6) or improvement (4-2) of symptoms. This scale was found to be a sensi tive and reliable method of detecting changes in response to treat ment [19].…”
Section: Methodsmentioning
confidence: 97%
“…In 1951, Shapiro [32] outlined the methodological difficulties in applying psychometric principles to diagnostic psychological testing. In the early 1970s, Kellner [33, 34] discussed the psychometric problems related to the assessment of changes in distress and introduced the concept of sensitivity, the ability of a rating or self-rating scale to discriminate between different groups of patients suffering from the same illness (e.g., depressed inpatients and outpatients) and to reflect changes in therapeutics, such as drug trials. In the past decade there has been an increasing number of trials in psychiatry that have failed to display significant differences between psychotropic drugs and placebo [35,36,37].…”
Section: The Misleading Effects Of Psychometric Theory On Clinical Asmentioning
confidence: 99%
“…who had evaluated them on intake but who did not take part in the treatment. Only patients rated as "better" or "much better" according to a global scale of improvement 15 and as being in full remission 19 were included in the study. Patients also had to show no evidence of depressed mood after treatment according to a modified version of the Paykel Clinical Interview for Depression (CID).…”
Section: Patientsmentioning
confidence: 99%